Quick Answer
ALBEMARLE CORP reported R&D Expense of $51.40 million for fiscal year 2025.
ALBEMARLE CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $51.40M | -40.7% |
| 2024 | $86.72M | +1.2% |
| 2023 | $85.72M | +19.1% |
| 2022 | $71.98M | +33.2% |
| 2021 | $54.03M | -8.8% |
| 2020 | $59.21M | +1.6% |
| 2019 | $58.29M | -16.8% |
| 2018 | $70.05M | -16.9% |
| 2017 | $84.33M | +4.8% |
| 2016 | $80.47M | -9.8% |
| 2015 | $89.19M | +1.0% |
| 2014 | $88.31M | +7.4% |
| 2013 | $82.25M | +4.2% |
| 2012 | $78.92M | +2.4% |
| 2011 | $77.08M | +32.0% |
| 2010 | $58.39M | -4.1% |
| 2009 | $60.92M | -9.5% |
| 2008 | $67.29M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.67M | -43.4% | +1.8% |
| June 30, 2025 | $12.44M | -40.1% | -11.7% |
| March 31, 2025 | $14.10M | -40.1% | -37.0% |
| September 30, 2024 | $22.40M | +6.2% | +7.8% |
| June 30, 2024 | $20.77M | -3.0% | -11.7% |
| March 31, 2024 | $23.53M | +15.0% | +11.6% |
| September 30, 2023 | $21.08M | +14.8% | -1.6% |
| June 30, 2023 | $21.42M | +23.2% | +4.6% |
- ALBEMARLE CORP showed a decrease of -40.7% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2025 period, ALBEMARLE CORP’s r&d expense has declined by 23.6% (from $67.29 million to $51.40 million).
- The most recent figure is from ALBEMARLE CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: